A Study of the COVID-19 Pandemic and Long-Lasting Symptoms in Thyroid and Diabetes Patients
Session Title
Other Abstracts
Faculty Mentor
Jennifer Bossi, Ph.D.| Janet Wojcik, Ph.D.| Dan Drane, Ph.D.
College
College of Education
Department
Physical Education, Sport & Human Performance
Abstract
COVID-19 has affected the whole world over the past few years. However, the prevalence of COVID-19 is much more common in those with autoimmune diseases, such as Diabetes Mellitus. This study examines the prevalence of COVID-19 in endocrinology patients, which were categorized as having a diabetic-related disorder, thyroid disorder, or another disorder.This study also examines if there is a connection between those with endocrine disorders, mainly Diabetes Mellitus, and thyroid-related disorders (such as hypothyroidism, Grave’s Disease, etc.) and if COVID-19 leads to specific after-effects. The hypothesis was that the prevalence of COVID-19, and the after-effects of having the disease, will be higher in populations with Diabetes type 1 and 2 than it would be in those with thyroid-related conditions. Surveys were collected at Lancaster Endocrinology, a Rock Hill doctor’s office that specializes in endocrine disorders. Surveys were given to patients in the office before they were seen by the doctor and were completely anonymous and voluntary. Then, data was compiled into graphs and charts. Based on the research data that was collected in the study at Lancaster Endocrinology, the numbers were almost even. However, those with long-term symptoms who were diabetic came in at 42.6%, slightly above the thyroid disorders at 40.7%. For future research, a wider population could be studied to see whether or not the same results were achieved.
Honors Thesis Committee
Jennifer Bossi, Ph.D., Janet Wojcik, Ph.D., Dan Drane, Ph.D.
Start Date
15-4-2023 12:00 PM
A Study of the COVID-19 Pandemic and Long-Lasting Symptoms in Thyroid and Diabetes Patients
COVID-19 has affected the whole world over the past few years. However, the prevalence of COVID-19 is much more common in those with autoimmune diseases, such as Diabetes Mellitus. This study examines the prevalence of COVID-19 in endocrinology patients, which were categorized as having a diabetic-related disorder, thyroid disorder, or another disorder.This study also examines if there is a connection between those with endocrine disorders, mainly Diabetes Mellitus, and thyroid-related disorders (such as hypothyroidism, Grave’s Disease, etc.) and if COVID-19 leads to specific after-effects. The hypothesis was that the prevalence of COVID-19, and the after-effects of having the disease, will be higher in populations with Diabetes type 1 and 2 than it would be in those with thyroid-related conditions. Surveys were collected at Lancaster Endocrinology, a Rock Hill doctor’s office that specializes in endocrine disorders. Surveys were given to patients in the office before they were seen by the doctor and were completely anonymous and voluntary. Then, data was compiled into graphs and charts. Based on the research data that was collected in the study at Lancaster Endocrinology, the numbers were almost even. However, those with long-term symptoms who were diabetic came in at 42.6%, slightly above the thyroid disorders at 40.7%. For future research, a wider population could be studied to see whether or not the same results were achieved.
